MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30
Rhea-AI Summary
MIMEDX (NASDAQ: MDXG) has scheduled its second quarter 2025 earnings conference call for July 30, 2025. The company will release its Q2 2025 operating and financial results after market close, followed by a management-hosted webcast and conference call at 4:30 p.m. Eastern Time.
Investors can access the call through the webcast or by phone using dedicated U.S. (877-407-6184) and international (201-389-0877) numbers with conference ID 13754722. A replay will be available on the company's website for approximately 30 days after the event.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, MDXG gained 6.00%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
MARIETTA, Ga., July 16, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2025 after the market close on Wednesday, July 30, 2025. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.
The conference call can be accessed using the following information:
Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13754722
A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com